Erschienen in:
01.10.2012 | Letter
Concerns regarding use of one-tailed tests in the SLED-BD vs. CVVH trial
verfasst von:
Gordon S Doig
Erschienen in:
Critical Care
|
Ausgabe 5/2012
Einloggen, um Zugang zu erhalten
Excerpt
In the previous issue of
Critical Care, I read with great interest the recent randomized controlled trial comparing sustained low-efficiency dialysis using a single-pass batch dialysis system (SLED-BD) with continuous veno-venous hemofiltration (CVVH) [
1]. I congratulate the authors on their undertaking but have serious concerns regarding the majority of their analysis. After each table at the end of the paper, the authors report the use of a 'one-tailed Wilcoxon test' to assess continuous outcomes. I do not believe this use is appropriate. …